Bionano Genomics
BNGO
32 hedge funds and large institutions have $417K invested in Bionano Genomics in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 5 closing their positions.
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
27% more capital invested
Capital invested by funds: $329K → $417K (+$88.3K)
10% more funds holding
Funds holding: 29 → 32 (+3)
0.48% less ownership
Funds ownership: 2.99% → 2.51% (-0.48%)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$195K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$160K |
| 3 |
CAM
Carret Asset Management
New York
|
+$79.5K |
| 4 |
HF
HRT Financial
New York
|
+$64.6K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$49.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$131K |
| 2 |
Morgan Stanley
New York
|
-$17.3K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7.26K |
| 4 |
SSG
Summit Securities Group
New York
|
-$3.93K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$531 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WANY
26
Wealthspire Advisors (New York)
New York
| $4 | +$6 | +2 | New |
|
27
Jones Financial Companies
Des Peres,
Missouri
| $3 | – | – | – |
|
|
AA
28
Ancora Advisors
Cleveland,
Ohio
| $2 | – | – | – |
|
29
Fifth Third Bancorp
Cincinnati,
Ohio
| $2 | – | – | – |
|
|
MWA
30
Medallion Wealth Advisors
Farmington,
Connecticut
| $2 | – | – | – |
|
|
AF
31
Aviso Financial
Toronto,
Ontario, Canada
| $1 | – | – | – |
|
|
GCP
32
GSA Capital Partners
London,
United Kingdom
| – | -$131K | -40,076 | Closed |
|
|
SSG
33
Summit Securities Group
New York
| – | -$3.93K | -1,199 | Closed |
|
34
Raymond James Financial
St Petersburg,
Florida
| – | -$243 | -74 | Closed |
|
|
SS
35
Sunbelt Securities
Houston,
Texas
| – | -$4 | -13 | Closed |
|
|
PW
36
Pandora Wealth
Oakbrook Terrace,
Illinois
| – | -$10 | -3 | Closed |
|
BNGO Hedge Fund Activity: Q3 2025 in Review
32 of the 7,626 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q3 2025, worth a combined $417K — up 27% from $329K a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new BNGO positions and 5 closed out — a net gain of 3 holders — while 5 added to existing stakes and 7 trimmed.
The largest buyer was UBS Group, adding an estimated $195K. The largest seller was GSA Capital Partners, exiting entirely with an estimated $131K sold.
- 32 institutional investors held Bionano Genomics (BNGO) as of Q3 2025, up from 29 in Q2 2025.
- Funds reported $417K of Bionano Genomics stock for Q3 2025, up 27% quarter-over-quarter.
- 8 funds opened new Bionano Genomics positions in Q3 2025 and 5 closed out, a net change of +3 holders.
- The largest Bionano Genomics buyer in Q3 2025 was UBS Group, an estimated $195K added.
- The largest Bionano Genomics seller in Q3 2025 was GSA Capital Partners, an estimated $131K sold.
Based on aggregated 13F filings for Q3 2025.